TRIB3 and renal cell carcinoma: First, while TRIB3 expression was assessed in a wide range of RCC cell lines, none were found to exhibit low endogenous TRIB3 levels at baseline, thus precluding gain-of-function experiments aimed at accurately recapitulating the true biological effects of TRIB3 on RCC cells.